Skip to main content

Table 5 Efficiency frontier and summary of cost-effectiveness results

From: Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France

Efficiency frontier (on-site reading)MRI with DW-MRINaF-PET/CTFCH-PET/CT
Life expectancy (years)5.505.786.11
QALYs4.454.674.93
Cost in Euros22,16022,38522,641
ICER: Euros per QALY gained 1002993
Efficiency frontier (central reading)NaF-PET/CTMRI with DW-MRIFCH-PET/CT
Life expectancy (years)5.875.876.03
QALYs4.734.734.87
Cost in Euros22,48122,06322,729
ICER: Euros per QALY gaineddominated 5055
  1. ICER Incremental cost-effectiveness ration; QALYs Quality-adjusted life expectancy